CVS vs SPRB · P/E 16, rev $402.07B vs rev $4.9M
CVS Health Corp (CVS) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the CVS and SPRB stock pages for the full models.
Not investment advice.